These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 11148857)

  • 1. Pharmacokinetics of nortilidine and naloxone after administration of tilidine/naloxone solution or tilidine/naloxone sustained release tablets.
    Brennscheidt U; Seiler KU; Thomann P
    Arzneimittelforschung; 2000 Nov; 50(11):1015-22. PubMed ID: 11148857
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of tilidine and naloxone in patients with severe hepatic impairment.
    Brennscheidt U; Brunnmüller U; Proppe D; Thomann P; Seiler KU
    Arzneimittelforschung; 2007; 57(2):106-11. PubMed ID: 17396621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bioavailability investigation of a new tilidine/naloxone liquid formulation compared to a reference formulation.
    Martin W; Ring J; Gaupp M; Arnold P; Sennewald R; Doser K
    Arzneimittelforschung; 1999 Jul; 49(7):599-607. PubMed ID: 10442208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contribution of CYP2C19 and CYP3A4 to the formation of the active nortilidine from the prodrug tilidine.
    Grün B; Merkel U; Riedel KD; Weiss J; Mikus G
    Br J Clin Pharmacol; 2012 Nov; 74(5):854-63. PubMed ID: 22381043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Poisoning with tilidine and naloxone: toxicokinetic and clinical observations.
    Regenthal R; Krüger M; Richter M; Preiss R
    Hum Exp Toxicol; 1998 Nov; 17(11):593-7. PubMed ID: 9865414
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of tilidine/naloxone, tramadol and bromfenac in experimental pain: a double-blind randomized crossover study in healthy human volunteers.
    Högger P; Rohdewald P
    Int J Clin Pharmacol Ther; 1999 Aug; 37(8):377-85. PubMed ID: 10475140
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pharmacokinetic aspects of the Valoron-N principle. Balanced pharmacokinetics of nortilidine and naloxone].
    Vollmer KO
    Fortschr Med; 1988 Oct; 106(29):593-6. PubMed ID: 3234997
    [No Abstract]   [Full Text] [Related]  

  • 8. Pre-systemic elimination of tilidine: localization and consequences for the formation of the active metabolite nortilidine.
    Eichbaum C; Mathes K; Burhenne J; Markert C; Blank A; Mikus G
    Basic Clin Pharmacol Toxicol; 2015 Feb; 116(2):129-33. PubMed ID: 25223231
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Topical review on the abuse and misuse potential of tramadol and tilidine in Germany.
    Radbruch L; Glaeske G; Grond S; Münchberg F; Scherbaum N; Storz E; Tholen K; Zagermann-Muncke P; Zieglgänsberger W; Hoffmann-Menzel H; Greve H; Cremer-Schaeffer P
    Subst Abus; 2013; 34(3):313-20. PubMed ID: 23844964
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of tilidine and metabolites in man.
    Vollmer KO; Thomann P; Hengy H
    Arzneimittelforschung; 1989 Oct; 39(10):1283-8. PubMed ID: 2610722
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sequential first-pass metabolism of nortilidine: the active metabolite of the synthetic opioid drug tilidine.
    Hajda JP; Jähnchen E; Oie S; Trenk D
    J Clin Pharmacol; 2002 Nov; 42(11):1257-61. PubMed ID: 12412825
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of tilidine in terminal renal failure.
    Seiler KU; Jähnchen E; Trenk D; Brennscheidt U; Heintz B
    J Clin Pharmacol; 2001 Jan; 41(1):79-84. PubMed ID: 11144998
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Actions of tilidine and nortilidine on cloned opioid receptors.
    Thierry C; Boeynaems JM; Paolo M
    Eur J Pharmacol; 2005 Jan; 506(3):205-8. PubMed ID: 15627429
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Tilidine/naloxon retard in long-term administration in chronic pain and multimorbidity. Multicenter study of long-term tolerance and effectiveness in 2 years observation].
    Flöter T; Brunnmüller U
    Fortschr Med Orig; 2002; 120(1):29-35. PubMed ID: 14518355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Management of chronic pain using extended release tilidine : Quality of life and implication of comedication on tilidine metabolism].
    Wolfert C; Merbach M; Stammler G; Emrich O; Meid AD; Burhenne J; Blank A; Mikus G
    Schmerz; 2017 Oct; 31(5):516-523. PubMed ID: 28597312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of tramadol and tilidine/naloxone on oral-caecal transit and pupillary light reflex.
    Freye E; Latasch L
    Arzneimittelforschung; 2000 Jan; 50(1):24-30. PubMed ID: 10683712
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Poisoning and severe ventilatory depression after oral ingestion of the industrially produced analgesic mixture tilidine with naloxone (Valoron N solution).
    Krüger M; Regenthal R; Richter M; Preiss R
    Intensive Care Med; 1998 Jul; 24(7):746. PubMed ID: 9722050
    [No Abstract]   [Full Text] [Related]  

  • 18. Oxycodone/naloxone preparation can cause acute withdrawal symptoms when misused parenterally or taken orally.
    Wong A; Macleod D; Robinson J; Koutsogiannis Z; Graudins A; Greene SL
    Clin Toxicol (Phila); 2015; 53(8):815-8. PubMed ID: 26109423
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of the active principle of the weak opioid tilidine by the triazole antifungal voriconazole.
    Grün B; Krautter S; Riedel KD; Mikus G
    Br J Clin Pharmacol; 2009 Nov; 68(5):712-20. PubMed ID: 19916995
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Valoron and Valoron N. A comparison of the analgesic effect and tolerance in various painful disorders in a medical practice].
    Peters-Haertel W
    ZFA (Stuttgart); 1980 Jan; 56(1):50-4. PubMed ID: 7368782
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.